Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ciarrocchi

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|May 16, 2014
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinomaGreta Gandolfi, Valentina Sancisi, Simonetta Piana, et al.
Cancer Research|March 15, 2015
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2Valentina Sancisi, Greta Gandolfi, Davide Carlo Ambrosetti, et al.
Oncogene|June 15, 2022
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulationSilvia Strocchi, Francesca Reggiani, Giulia Gobbi, et al.
Frontiers in Oncology|April 30, 2021
Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining LymphomagenesisValentina Fragliasso, Annalisa Tameni, Giorgio Inghirami, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2012
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomasValentina Sancisi, Davide Nicoli, Moira Ragazzi, et al.
Cell Death & Disease|December 9, 2016
Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancerMila Gugnoni, Valentina Sancisi, Gloria Manzotti, et al.
Molecular Cancer|January 31, 2025
lncRNAs: the unexpected link between protein synthesis and cancer adaptationMila Gugnoni, Manoj Kumar Kashyap, Kishore K Wary, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2010
Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cellsAlessia Ciarrocchi, Simonetta Piana, Roberto Valcavi, et al.
Experimental & Molecular Medicine|December 18, 2025
EGLN1 (PHD2) role in tumor microenvironment: insights for therapeutic targetingGiulio Verna, Valentina Fantini, Alessandra Grieco, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 14, 2020
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapyFrancesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|May 16, 2014
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinomaGreta Gandolfi, Valentina Sancisi, Simonetta Piana, et al.
Cancer Research|March 15, 2015
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2Valentina Sancisi, Greta Gandolfi, Davide Carlo Ambrosetti, et al.
Oncogene|June 15, 2022
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulationSilvia Strocchi, Francesca Reggiani, Giulia Gobbi, et al.
Frontiers in Oncology|April 30, 2021
Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining LymphomagenesisValentina Fragliasso, Annalisa Tameni, Giorgio Inghirami, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2012
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomasValentina Sancisi, Davide Nicoli, Moira Ragazzi, et al.
Cell Death & Disease|December 9, 2016
Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancerMila Gugnoni, Valentina Sancisi, Gloria Manzotti, et al.
Molecular Cancer|January 31, 2025
lncRNAs: the unexpected link between protein synthesis and cancer adaptationMila Gugnoni, Manoj Kumar Kashyap, Kishore K Wary, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2010
Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cellsAlessia Ciarrocchi, Simonetta Piana, Roberto Valcavi, et al.
Experimental & Molecular Medicine|December 18, 2025
EGLN1 (PHD2) role in tumor microenvironment: insights for therapeutic targetingGiulio Verna, Valentina Fantini, Alessandra Grieco, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 14, 2020
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapyFrancesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, et al.
Pageof 13